Pharma Journalist - Page 99 of 946 -

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

Sandoz and Henlius Expand Global Biosimilar Collaboration

FDA Approves Biocon’s Jobevne, Bevacizumab Biosimilar

FDA to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Drugs

Renovaro and BioSymetrics Complete Merger to Boost AI-Driven Biomarker Discovery and Precision Medicine

Epsilogen Acquires TigaTx to Lead Pan-Isotype Cancer Antibody Market

ALX Oncology Gets FDA IND Clearance for EGFR-targeted Antibody-Drug Conjugate ALX2004

Avidity Biosciences Wins Orphan Drug Designation in Japan for Delpacibart Etedesiran

Engine Biosciences and EDDC Partner to Advance Cancer Therapies

Poxel Gains Approval to Expand TWYMEEG Indication for Type 2 Diabetes with Renal Impairment in Japan

ABL Bio Signs License Deal with GSK for Grabody-B Brain Delivery Platform

CAS and Cleveland Clinic Collaborate to Boost Research with AI and Quantum Computing